药剂师对跨专业合作的态度,以优化瑞士老年患者的药物使用:一项调查研究
Renata Vidonscky Lüthold1,2, Damien Cateau3, Stephen Philip Jenkinson1,3
1Institute of Primary Health Care (BIHAM), University of Bern, 3012, Bern, Switzerland.
BMC health services research
|July 26, 2024
概括
药剂师愿意为老年人推抑郁症,但缺乏正式培训. 他们希望在瑞士初级医疗保健中更多地参与药物审查和处方过程.
科学领域:
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
- 主要护理是指初级护理.
背景情况:
- 医生和药剂师的合作对于药物优化至关重要.
- 药剂师经常建议抑郁症,但影响这种因素和瑞士初级保健中的专业间协作是不充分研究的.
- 了解这些动态是改善老年人药物管理的关键.
研究的目的:
- 探索瑞士药剂师对药物优化和老年患者抑郁症的看法.
- 了解药剂师在初级保健机构的专业间合作的偏好.
- 确定影响药剂师推抑郁处方的意愿因素.
主要方法:
- 在瑞士,向1000名药剂师分发了一项横截面调查.
- 参与者对老年人 (≥80岁) 的病例简介做出了反应,其中包括多种药物,日常生活活动 (ADL) 依赖和心血管疾病 (CVD).
- 多级逻辑回归分析了心血管疾病,ADL和愿意去描述之间的关联.
主要成果:
- 138名药剂师做出了回应;66%的药剂师缺乏在结构化药物评价方面的具体培训.
- 所有药剂师都愿意停止至少一种药物的处方.
- 抑郁症的几率较低与心血管疾病 (CVD) 和日常生活活动 (ADL) 的依赖程度较高有关,ADL和CVD之间有显著的相互作用.
结论:
- 瑞士药剂师愿意建议对多种药物治疗的老年患者进行抑郁处方.
- 很大一部分人缺乏在结构化药物评价方面的正式培训.
- 药剂师表示希望更多地参与药物审查和处方,强调在瑞士初级保健中加强合作的机会.
相关概念视频
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
53
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
53
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
110
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
110
Factors Affecting Protein-Drug Binding: Patient-Related Factors
50
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
50


